PERCEVAL ™

First Patient Enrolled in the PERSIST-AVR Trial at CHU Brabois, University of Lorraine, Nancy – France

Discover more

MEMO 3D RECHORD

LivaNova receives regulatory approval in Canada for its innovative Memo 3D ReChord annuloplasty ring for mitral valve repair

Discover more

PERCEVAL

LivaNova announces the first U.S. implant of Perceval, the only sutureless valve for aortic valve replacement surgery

Discover more

SOLO SMART

LivaNova receives regulatory approval in Japan for the Solo Smart stentless tissue aortic valve

Discover more

CROWN PRT ™

LivaNova announces FDA approval of stented heart valve CROWN PRT ™ for aortic valve disease

Discover more

KORA 250 now approved in Japan

World’s smallest full body MRI conditional pacing system with extended longevity and proprietary technologies designed to improve patient outcome

Discover more

Latest News

May 5, 2016

SonR: 35% Risk Reduction in Heart Failure Hospitalization

READ MORE

May 4, 2016

LivaNova Reports First Quarter 2016 Results

READ MORE

Apr 6, 2016

LivaNova, PLC to Report 2016 First Quarter Results and Host Webcast and Conference Call on May 4, 2016

READ MORE

Apr 4, 2016

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

READ MORE

Mar 22, 2016

First Implant in Japan of KORA 250, The World’s Smallest Full Body MRI Conditional Pacing System

READ MORE

In the Spotlight

Version unknown | Revision 87259 | Status unstable | SessionId 142BECFBBFB64CCBABA074327E68C5E2.jvm1